MedPath

The effect of Chromium picolinate in Non-Alcoholic Fatty Liver

Phase 2
Recruiting
Conditions
on-alcoholic fatty liver.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT20100123003140N15
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Patients who agree to participate in the study
Men and women aged 20 to 50 years
BMI ranges from 25 to 40 kg / m 2
Increased levels of ALT and AST are higher than normal levels
Grade 2, 3, and 4 diseases

Exclusion Criteria

kidney disease
Thyroid gland problems
Uncontrolled blood pressure
Taking statin
Hepatitis C and B
Cytomegalovirus
Pregnancy
alcohol consumption
Wilson
Hocromatosis
Deficiency of alpha-1 antitrypsin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DL. Timepoint: First and three months after the start of the study. Method of measurement: Enzyme colorimetry.;HDL. Timepoint: First and three months after the start of the study. Method of measurement: Enzyme colorimetry.;TNF-a. Timepoint: First and three months after the start of the study. Method of measurement: ELISA Kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath